ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · IEX Real-Time Price · USD
11.40
-0.15 (-1.30%)
At close: Jul 2, 2024, 4:00 PM
11.46
+0.06 (0.51%)
After-hours: Jul 2, 2024, 7:54 PM EDT
ADMA Biologics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for ADMA Biologics stock have an average target of 11, with a low estimate of 10 and a high estimate of 14. The average target predicts a decrease of -3.51% from the current stock price of 11.40.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for ADMA Biologics stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Strong Buy Maintains $12 → $14 | Strong Buy | Maintains | $12 → $14 | +22.81% | Jun 20, 2024 |
| Raymond James | Raymond James | Strong Buy Maintains $8 → $10 | Strong Buy | Maintains | $8 → $10 | -12.28% | May 10, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $8 → $10 | Buy | Maintains | $8 → $10 | -12.28% | May 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $7.5 → $10 | Strong Buy | Maintains | $7.5 → $10 | -12.28% | May 10, 2024 |
| Mizuho | Mizuho | Strong Buy Maintains $10 → $12 | Strong Buy | Maintains | $10 → $12 | +5.26% | May 10, 2024 |
Financial Forecast
Revenue This Year
364.65M
from 258.22M
Increased by 41.22%
Revenue Next Year
422.77M
from 364.65M
Increased by 15.94%
EPS This Year
0.36
from -0.13
EPS Next Year
0.55
from 0.36
Increased by 53.19%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 378.7M | 440.4M | 503.5M | 566.8M | 615.6M |
| Avg | 364.7M | 422.8M | 481.1M | 529.1M | 554.8M |
| Low | 348.3M | 403.0M | 453.8M | 471.8M | 491.6M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 46.6% | 20.8% | 19.1% | 17.8% | 16.4% |
| Avg | 41.2% | 15.9% | 13.8% | 10.0% | 4.9% |
| Low | 34.9% | 10.5% | 7.3% | -1.9% | -7.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 0.39 | 0.62 | 0.68 | 0.79 | 0.68 |
| Avg | 0.36 | 0.55 | 0.62 | 0.72 | 0.66 |
| Low | 0.31 | 0.45 | 0.52 | 0.65 | 0.64 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 72.3% | 23.9% | 28.0% | -5.1% |
| Avg | - | 53.2% | 11.7% | 16.9% | -7.8% |
| Low | - | 25.4% | -5.7% | 5.1% | -11.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.